Why the study?
Is the PHQ-9 a valid screening tool for suicidal ideation in patients with inflammatory bowel disease?
Is the PHQ-9 a valid screening tool for suicidal ideation in patients with inflammatory bowel disease?
The PHQ-9 is a highly sensitive screening tool with excellent negative predictive value for identifying suicidal ideation in patients with inflammatory bowel disease.
Answers are grounded in this paper and cite their sources.
PHQ-9 may help exclude suicidal ideation in IBD; leaves open confirmatory testing needs and prospective validation.
Background: Suicide is a leading cause of death worldwide. Transition from suicidal ideation (SI) to suicide attempt is high within a year of SI onset. The risk of suicide and SI is elevated in persons with inflammatory bowel disease (IBD) versus the general population. We aimed to validate the Patient Heath Questionnaire (PHQ)-9 as a screening tool for SI in IBD and to determine factors associated with SI in IBD. Methods: IBD participants (n = 247) recruited from the community and clinics completed the PHQ-9 and participated in the Structured Clinical Interview for DSM-IV (SCID). We determined the sensitivity, specificity, and positive and negative predictive value (PPV and NPV) of the PHQ-9 in identifying SI as compared to the SCID. Using logistic regression we examined the association of SI with demographic and clinical factors. Results: SI was endorsed by 24 (9.7%) participants on the PHQ-9 and 5 (2.0%) based on the SCID. The PHQ-9 had good sensitivity (100%), specificity (92.2%), and NPV (100%) but low PPV (20.8%) for SI. On univariate analysis, factors strongly associated with SI were depression (OR 13.1; 95%CI: 4.46, 40.5), anxiety (OR 11.3; 95%CI: 4.46, 28.6), and active disease (OR 3.87; 95%CI: 1.54, 9.71). On multivariable analysis, depression (OR 5.54; 95%CI: 1.67, 18.4) and pain (OR 1.14; 95%CI: 1.03, 1.25) were associated with SI. Conclusions: Overall the PHQ-9 is a valid screening tool for SI in IBD patients, and routine implementation of this tool would support screening for depression and SI effectively and efficiently in clinical practice.
No takes yet. Share an insight, caveat, or question.
Litster et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: